Related Experiment Video
Updated: May 12, 2026

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
Clinical and physiological heterogeneity in slow transit constipation: a review of 122 patients
1Academic Department of Surgery, St Bartholomew's and the Royal London School of Medicine & Dentistry, London, UK.
Objective:
The outcome of surgery in patients with slow transit constipation (STC) is unpredictable. This may reflect clinical and physiological heterogeneity within this group of patients. This study attempts to identify subgroups of patients with STC according to clinical history, and compares the pathophysiological findings between the two largest: including patients with chronic idiopathic STC, and those with symptoms acquired after pelvic surgery or childbirth (post-pelvic intervention STC).
Patients And Methods:
Review of clinical and gastrointestinal pathophysiological findings of 122 consecutive patients with slow colonic transit.
Results:
Six subgroups of patients were defined according to the time and nature of onset of symptoms. Pathophysiological comparison of the two main groups: chronic idiopathic STC (n=65 (53%)) and post-pelvic intervention STC (n=22 (18%)), yielded three main conclusions: (i) the pattern of colonic transit is similar in both groups, i.e. predominantly (approximately 70%) generalized; (ii) the prevalence of a rectal evacuatory disorder is significantly higher in patients with post-pelvic intervention STC (77% vs 32%, P=0.004); and (iii) small bowel motility disturbances occur in both groups (overall 48%), and are therefore not limited to patients with chronic idiopathic STC.
Conclusion:
There are pathophysiological similarities and differences between the main two subgroups of STC. Such findings may help our understanding of the pathogenesis and have implications in the future management of these patients.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Gastrointestinal Motility Disorders